Effects of Motor Imagery Technique With and Without Virtual Reality on Pain Intensity ,Functional Disability and Quality of Life in Patient With Post Stroke Shoulder Hand Syndrome

NCT07610889 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-05-28

No results posted yet for this study

Summary

the current study is a randomized controlled trial comparing the effectiveness of motor imagery techanique with and without virtual reality on pain intensity , functional disability and quality of life for individual with post stroke shoulder hand syndrome . this trial aims to evaluate pain , functional disability and overall quality of life . the primary outcome is pain reduction . while seconday outcome reduce disability and improve quality of life .the hypothesis is that the combination of motor imagery and virtual reality will result in significant greater clinical improvement compared to motor imagery alone .

Conditions

  • Complex Regional Pain Syndrome (CRPS)
  • Shoulder Hand Syndrome

Interventions

OTHER

motor imagery with virtual reality

participants will receive 30 minute intervention session .the integrated components consist of motor imagery and virtual reality followed by the application of affected arease

OTHER

motor imagery alone

participant will receive same 30 minutes session of specializes motor imagery techniques . no virtual reality sessions are included

Sponsors & Collaborators

  • Green International University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-02
Primary Completion
2026-04-29
Completion
2026-05-06

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07610889 on ClinicalTrials.gov